How A Drugmaker Gamed The System to Keep Generic Competition Away
Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.
Read more on NPR
May 17, 2018 at 04:00PM
Health Care
NPR News: How A Drugmaker Gamed The System to Keep Generic Competition Away
Posted by Unknown |
16:05
Related Posts:
NPR News: Legislation That Would Shape FDA And NIH Triggers Lobbying FrenzyLegislation That Would Shape FDA And NIH Triggers Lobbying Frenzy More than 1,455 lobbyists weighed in on the 21st Century Cures Act in this congressi… Read More
NPR News: Pence Expanded Medicaid As Governor, Now He May Be Part Of Cutting ItPence Expanded Medicaid As Governor, Now He May Be Part Of Cutting It Indiana Gov. Mike Pence expanded access to Medicaid with a conservative twist. H… Read More
NPR News: Pence Expanded Medicaid As Governor, Now He May Be Part Of Cutting ItPence Expanded Medicaid As Governor, Now He May Be Part Of Cutting It Indiana Gov. Mike Pence expanded access to Medicaid with a conservative twist. H… Read More
NPR News: In Conservative Poland, People Pushed Back In Battle Over Aborton RightsIn Conservative Poland, People Pushed Back In Battle Over Aborton Rights Poland has some of the most restrictive abortion laws in Europe, but the righ… Read More
NPR News: Legislation That Would Shape FDA And NIH Triggers Lobbying FrenzyLegislation That Would Shape FDA And NIH Triggers Lobbying Frenzy More than 1,455 lobbyists weighed in on the 21st Century Cures Act in this congressi… Read More
0 nhận xét:
Đăng nhận xét